Related Experiment Video
Updated: Jun 17, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Immune modulation of blood-derived stem cell as a comprehensive tool for treating type 1 diabetes
Yong Zhao1, David Hwang, Chengshan Guo
1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA. yongzhao@uic.edu
Abstract:
Type 1 diabetes (T1D) is an autoimmune disease in which the patient's immune system recognizes their pancreatic islet insulin-producing cells and destroys them. To cure T1D in a comprehensive manner, not only must the islet cells be replaced, the patient's immune system must also be properly regulated mostly in the form of suppression. Blood-derived new stem cells have shown promise in both aspects of this treatment.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Type I Diabetes II: Pathophysiology
iPS Cell Differentiation
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Mesenchymal Stem Cells
